Congress took an important step to bring safe and effective treatments and cures to patients by passing the Food and Drug Administration (FDA) Reauthorization Act of 2017.
The Bipartisan Policy Center applauds the Senate HELP Committee for passing the Food and Drug Administration Reauthorization Act of 2017.
The bill provides a $2 billion increase in funding for the National Institutes of Health (NIH) to support important research.
User fees play a critical role in providing the FDA the resources it needs to maintain the gold standard in both the review and approval of drugs
Timely completion and passage of FDA user fee reauthorization legislation is a crucial next step toward helping Americans in need.
The bigger concern is the fact that it takes more than ten years and $2 billion to develop a new drug from a molecule to a medicine.
Congress has four remaining work weeks in Washington to hash out the budget and hopefully finish work on the “21st Century Cures” legislation.